Clinical Trial Update: Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease [NA]

View source ↗

Summary

A feasibility study by Baylor College of Medicine is evaluating the Paso Program for patients with metabolic dysfunction-associated steatotic liver disease, ove…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Metabolic Syndrome

Snippet

Sponsor: Baylor College of Medicine | Conditions: Metabolic Dysfunction Associated Steatotic Liver Disease, Overweight (BMI > 25) | NA | Status: ACTIVE_NOT_RECRUITING